Cell- and Tissue-Based Therapy
"Cell- and Tissue-Based Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.
Descriptor ID |
D064987
|
MeSH Number(s) |
E02.095.147
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell- and Tissue-Based Therapy".
Below are MeSH descriptors whose meaning is more specific than "Cell- and Tissue-Based Therapy".
This graph shows the total number of publications written about "Cell- and Tissue-Based Therapy" by people in this website by year, and whether "Cell- and Tissue-Based Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 1 | 2 |
2008 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 1 | 2 | 3 |
2014 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2018 | 3 | 0 | 3 |
2019 | 1 | 1 | 2 |
2020 | 2 | 0 | 2 |
2021 | 0 | 2 | 2 |
2022 | 1 | 7 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell- and Tissue-Based Therapy" by people in Profiles.
-
Non-viral precision T?cell receptor replacement for personalized cell therapy. Nature. 2023 Mar; 615(7953):687-696.
-
Management of endothelial disease without keratoplasty. Curr Opin Ophthalmol. 2022 Jul 01; 33(4):332-337.
-
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up. J Clin Oncol. 2023 02 20; 41(6):1265-1274.
-
Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy. J Transl Med. 2022 05 23; 20(1):241.
-
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients. Transplant Cell Ther. 2022 05; 28(5):225-232.
-
Exudative Retinal Detachment Following Chimeric Antigen Receptor T-Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia. Ophthalmic Surg Lasers Imaging Retina. 2022 02; 53(2):113-115.
-
Engineering tumor stromal mechanics for improved T cell therapy. Biochim Biophys Acta Gen Subj. 2022 04; 1866(4):130095.
-
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design. Am J Nephrol. 2022; 53(1):50-58.
-
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 06 17; 137(24):3454-3459.
-
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. Leuk Lymphoma. 2021 06; 62(6):1497-1501.